The South America Fluoroscopy Market size is estimated at USD 348.47 million in 2024, and is expected to reach USD 433.02 million by 2029, growing at a CAGR of 4.44% during the forecast period (2024-2029).
Fluoroscopy devises market is primarily driven by rising demand for minimally-invasive surgeries, growing geriatric population, the prevalence of chronic diseases, and increasing use of fluoroscopy in pain management.
Medical imaging has applications at various stages of inpatient management processes, such as diagnosis, staging, therapy delivery, and its follow-ups. The primary role for imaging has been diagnostics, but it is increasing slowly for interventional diagnostics and therapeutic uses that are driven by minimally-invasive procedures. Fluoroscopy presents real-time moving images for the diagnostic evaluation of soft and hard tissue conditions. It is an indispensable tool for many interventional medical procedures. The fluoroscopy market is anticipated to register significant growth, with an increasing number of minimally-invasive surgeries that are of high-precision, including the devices used, resulting in better support for both patients and surgeons. The growing preference for minimally-invasive procedures is due to benefits, such as the lower risk of complications, reduced cost, and lesser recuperation period, less pain, small incisions, and less scarring, which have contributed to the growth of the market. The use of fluoroscopy in pain management is expected to supplement the growth of the market. However, the side effects associated with radiation is expected to hinder the market growth over the forecast period.
Cardiovascular procedures require extensive fluoroscopic guidance to navigate endovascular catheters. The fluoroscopy provides excellent spatial and temporal resolution, having a limitation of exposure of ionizing radiation to the patients and staff, along with poor soft tissue characterization. In the process of cardiac catheterization, fluoroscopy is used to help the healthcare provider see the flow of blood through the coronary arteries to check for arterial blockages. Therefore, the rising prevalence of cardiovascular diseases across the region is a major factor driving the growth of the market. According to an article published in the journal Circulation, in 2017, cardiovascular disease has been the main cause of death in Brazil since the end of the 1960s. the reasons for the maintenance of the ranking is due to the lifestyle changes related to urbanization and globalization and the rapid population aging caused by greater life expectancy and lower fertility.
The market is consolidated, owing to the presence of a few major players in the market. The major market players are focusing on technological advancements and reducing the side effects of the procedures. Some of the major players in the market are Canon Medical Systems Corporation, GE Healthcare, Hitachi Medical Systems, Hologic Inc., Koninklijke Philips NV, Shimadzu Medical, and Siemens Healthineers.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook